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Abstract
Background: Coagulase-negative staphylococci (CoNS) represent 
one of the major resistant nosocomial pathogens where its biofilm-
related infections often fail to respond to antibiotic chemotherapy. 
Here, we studied the resistance profiles and biofilm formation in CoNS 
isolates from clinical specimens at Al Shifa hospital in Gaza, Palestine.
Methods: This study was carried out from March to July 2013 and 
included 81 clinical isolates. Identification and antibiotic susceptibility 
testing were performed using VITEK-2 system. The presence of nuc 
and mecA genes was performed using multiplex PCR. Qualitative and 
quantitative biofilm assays were performed using standard methods. 
Results: Of the 81 clinical CoNS isolates, S. haemolyticus was the most 
common species (34, 42%), followed by S. epidermidis (26, 32.1%) and 
S. saprophyticus (13, 16%). The majority of isolates (83.9%) were from 
surgery, ICUs, pediatrics and medicine wards and the most common 
source was pus (28, 34.6%). Antibiotic resistance was highest aga-
inst aminoglycosides, β-lactams, carbapenems, cephalosporins, fluo-
roquinolones, fosfomycin and macrolides. Though, no resistance was 
detected against rifampicin, vancomycin, teicoplanin, nitrofurantoin, 
linezolid and mupirocin. The antibiotic resistance among MR-CoNS 
was significantly higher than that among MS-CoNS. Nearly 88.9% of 
isolates were multidrug resistant with higher percentage among MR-
CoNS. Most S. epidermidis (76.9%) isolates were biofilm producer, 
with statistically significant association between methicillin resistance 
and biofilm production.
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Introduction
Coagulase-negative staphylococci (CoNS) are now 
representing one of the major nosocomial patho-
gens and among the most frequently isolated bac-
teria in the clinical microbiology laboratories [1-5]. 
They are responsible for bacteremia, endocarditis, 
mediastinitis, meningitis and progressive joint des-
truction mainly in patients with neutropenia, indwe-
lling foreign devices, intravascular catheters or other 
foreign bodies [1, 3, 4]. The clinical most relevant 
CoNS are Staphylococcus epidermidis, S. lugdunen-
sis, S. saprophyticus , and S. capitis [6, 7].
Biofilm production by CoNS, specially S. epider-
midis , is considered as an important factor in the 
pathogenesis of implanted medical devices associa-
ted infections [1, 2, 8, 9]. Biofilm formation takes 
place in four successive phases: the attachment of 
the bacteria to biotic or abiotic surface; the prolife-
ration and accumulation of bacteria in multilayered 
cell clusters; the growth of biofilm into a thick and 
structured layer, and finally the detachment and cir-
culation of single cells or cell agglomerates via the 
bloodstream [1, 2].
Many literature surveys revealed that CoNS showed 
high resistance against most of the commonly used 
therapeutic antibacterial agents including methicillin. 
Irrespective of geographical locations, a worldwide 
SENTRY study showed that, about 70-75% of CoNS 
are resistant to methicillin [10]. There is a significant 
increase in the methicillin-resistant coagulase nega-
tive staphylococci (MR-CoNS) infections and these 
bacteria have recently started to gain resistance to 
other widely used antibiotics [11-14]. 
The increased recognition of pathogenic potential 
of CoNS and emergence of drug resistance among 
them justify the need to identify various species of 
CoNS and determine their antibiotic resistance pat-
tern. Epidemiological data about CoNS in Palestine 
are either scarce or insufficient [15]. To the best of 
our knowledge, this is the first report describing cli-
nical CoNS infection within the Gaza Strip hospitals. 
To that end, we conducted this study to determine 
the frequency of CoNS species isolated from various 
clinical specimens and to assess their resistance pro-
file to most commonly used antibiotics at Al Shifa 
hospital in Gaza Strip. Moreover, biofilm forming 
capacity of S. epidermidis isolates was investigated.
Materials and Methods
Study design and setting 
This study was conducted for five months between 
March and July 2013 at the clinical microbiology 
laboratory of the largest medical complex hospital 
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Conclusions: High rates of antibiotic resistance were found among 
CoNS to commonly used antibiotics and the majority were methicillin 
and multidrug resistance. Most S. epidermidis isolates were biofilm 
producer. These results justified the necessity for national programs 
and measures to monitor and manage the usage of antibiotics in the 
Palestinian hospitals and community. 
Received 11-01-2018; Accepted 25-01-2018
The InTernaTIonal arabIc Journal of anTImIcrobIal agenTs 
ISSN: 2174-9094
2017
Vol. 7 No. 3:4
doi: 10.3823/814
© Under License of Creative Commons Attribution 4.0 License 3
in Gaza Strip, Al-Shifa hospital with 500 acute care 
beds. The study was approved by the department 
of human resources and development in the minis-
try of health (MOH) and by the Helsinki commit-
tee at the MOH in Gaza Strip (Approval no. PHRC/
HC/36/14).
Sampling and bacterial isolates
Eighty one non-duplicate CoNS isolates associated 
with diverse clinical infections were collected. The 
isolates represent different sources including pus, 
urine, blood, sputum, burn and surgical swabs of 
hospitalized patients in surgery, pediatrics, medici-
ne, burns, gynecology and ICUs departments. These 
isolates were collected in 2013, out of a total unique 
1121 bacterial isolates. 
Isolation and Identification of CoNS and 
MR-CoNS
Conventional techniques
CoNS isolates were identified phenotypically based 
on colonial morphology, Gram stain, and by using 
the following methods: catalase test, tube coagu-
lase test, Pastorex™ Staph Plus latex agglutination 
(Bio-Rad, Hercules, California), and the Staph ID 32 
API system (bioMérieux, France) according to the 
manufacturer’s instructions. VITEK-2 automated sys-
tem was used to identify CoNS to the species level 
using VITEK-2 database, version 4.03 (bioMérieux, 
Marcy l’Etoile, France). Screening for MR-CoNS was 
done by testing for oxacillinand cefoxitinresistan-
ce using the VITEK-2 Compact Gram Positive Card 
(bio-Mérieux, Paris, France).
Molecular techniques
DNA isolation: Isolates were overnight subcultured 
in brain heart infusion broth and pelleted by cen-
trifugation at 5, 000 rpm for 15 min, resuspended 
in 185 µl of TE buffer (20 mMTris chloride, 2 mM 
EDTA [PH 8.0]) with 15 µl of recombinant lysosta-
phin (15 mg/ml; Sigma, St. Louis, Mo.) and incuba-
ted at 37°C for 30 min, then boiled at 95°C for 15 
minutes. After cooling to room temperature, the 
suspension was centrifuged at 10, 000 rpm for 5 
minutes, and the supernatant was used directly as 
template for PCR reactions [16].
Detection of nuc and mecA genes:A multiplex 
PCR assay was used for detection of the nuc gene 
to exclude any coagulase negative S. aureus isolate 
and mecA gene for detection of methicillin-resis-
tance among CoNS isolates [17, 18].Briefly, primers 
mecA-1 (5'-GGGATCATAGCGTCATTATTC-3') and 
mecA-2 (5'-AACGATTGTGACACGATAGCC-3') for 
the gene mecA and nuc-1 (5'-TCAGCAAATGCAT-
CACAAACAG-3') and nuc-2 (5'-CGTAAATGCACTT-
GCTTCAGG-3') for the gene nuc were used in a 
multiplex PCR reaction on a T100™ Thermal Cycler 
(BioRad, USA) under the following conditions: an 
initial 5-min denaturation step at 95°C, followed by 
30 cycles of 1 min of denaturation at 95°C, 1 min of 
annealing at 59°C, and 2 min of extension at 72°C; 
with a final extension step at 72°C for 10 min. The 
sizes of the amplicons were 530bp and 280bp for 
mecA and nuc genes, respectively. 
Antimicrobial susceptibility testing
Antibiotic susceptibility testing for the CoNS isolates 
was performed with the automated VITEK-2 Com-
pact automated system, using the VITEK-2 Compact 
Gram Positive Card (bio- Mérieux, Paris, France); 
Multidrug-resistant (MDR) phenotype was defined 
as acquired non-susceptibility to at least one agent 
in three or more antimicrobial categories used in 
this study [19].
Biofilm production
The biofilm forming capacity of only S. epidermidis 
strains was investigated qualitatively and quantita-
tively by methods previously described. For quali-
tative biofilm production, a simple method using 
growth on Congo red agar (CRG) for detecting 
biofilm formation was used [20]. With brain heart 
infusion agar containing Congo red stain at 0.8 g/
liter (BDH Chemicals Ltd., Poole, United Kingdom), 
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biofilm-positive strains yield black colonies with a 
dry crystalline surface appearance, while biofilm-
negative strains mostly give a red colonies. 
For quantification assay of biofilm-forming capa-
city, tests similar to those described previously were 
applied [9, 21, 22]. Briefly, S. epidermidis strains 
were cultivated overnight in 10 ml of tryptic soy 
broth (TSB) supplemented with 0.25% (wt/vol) glu-
cose. Cultures were diluted in TSB supplemented 
with 0.25% (wt/vol) glucose to a final OD578 of 
0.1 and 200 µl of the cell suspension was used to 
inoculate sterile, 96-well flat-bottom polystyrene 
microtiter plates (Greiner bio-one; Cellstar). After 
cultivation for 24 h at 37°C, the wells were emptied 
and the contents were gently washed three times 
with 200 µL of PBS (pH 7.2) to remove free-floating 
planktonic bacteria. The plates were air dried for 
10 min., and the remaining surface-adherent cells 
were stained with 0.1% safranin (Serva) for 30 s. 
Absorbance at 490 nm (A490) was measured with 
a Micro-ELISA Autoreader (SpectraMAXGeminiXS; 
Molecular Devices). Wells containing only sterile TSB 
served as a background control; their average A490 
value was subtracted from all experimental readings. 
S. epidermidis RP62A and S. carnosus TM300 were 
used as positive and negative controls, respectively. 
Each assay for each strain was performed in qua-
druplicate.
Statistical analysis
The results were tabulated, encoded and statisti-
cally analyzed using Statistical Package for Social 
Sciences (SPSS®) program version 17 (Chicago, IL, 
USA). Fisher's exact 2-tailed and Pearson's χ2 tests 
were used for categorical variables to compare fre-
quencies of CoNS species and MR-CoNS positivity 
and negativity. Likewise, percentages as of antibiotic 
resistance profiles of MR-CoNS and MS-CoNS were 
compared with Pearson's χ2 or Fisher's exact test as 
appropriate. P-value were calculated and P< 0.05 
was considered statistically significant. 
Results
Identification and distribution of CoNS 
and MR-CoNS species
 Out of a total 1121 bacterial isolates, 81 strains of 
CoNS that belong to six species were identified. S. 
haemolyticus was the most common species isolated 
(34, 42%), followed by S. epidermidis (26, 32.1%) 
and S. saprophyticus (13, 16%) (Table 1). CoNS were 
Table 1.  Distribution of the 81 CoNS isolates accor-
ding to gender, ward, type of specimen, 
species and resistance to methicillin.
No. % P-value
Gender
Males 42 51.9
0.47
Females 39 48.1
Ward
Surgery 23 28.4
0.86
ICUs 17 21
Pediatrics 15 18.5
Medicine 13 16
Burns 10 12.3
Gynecology 3 3.7
Specimen
Pus 28 34.6
0.15
Swaba 19 23.5
Urine 15 18.5
Blood 12 14.8
Sputum 3 3.7
Othersb 4 4.9
Specimen
S. haemolyticus 34 42
S. epidermidis 26 32.1
S. saprophyticus 13 16
S. hominis 5 6.2
S. warneri 2 2.5
S. auricularis 1 1.2
Specimen
Resistant 60 74.1
<0.001*
Susceptible 21 25.9
Total 81 100
ICUs: Intensive Care Units. a: Swabs including surgical site infections 
and burn swabs. b: Others including cerebrospinal, pleural, synovial 
and ascetic fluids. *: Statistical significant difference.
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isolated from 42 (51.9%) males and 39 (48.1%) fe-
males. The majority of CoNS isolates (83.9%) were 
from surgery, ICUs, pediatrics and medicine wards. 
Of the ten specimen sources, the most common 
source of CoNS was pus (28, 34.6%), followed by 
swabs (19, 23.5%), urine (15, 18.5%) and blood 
(12, 14.8%). Screening for MR-CoNS revealed that 
60 (74.1%) were MR-CoNS and 21 (25.9%) were 
MS-CoNS. There were no statistically significant di-
fferences in the distribution of CoNS according to 
gender, hospital ward and specimen source (P = 
0.47, 0.86, and 0.15 respectively). Yet, a statistically 
significant difference was found between MR-CoNS 
and MS-CoNS (P< 0.001) (Table 1).
As stated in Table 2, the highest numbers of S. 
haemolyticus and S. epidermidis strains were reco-
vered from pus specimens (41.2%, 34.6% respec-
tively), while S. saprophyticus was mainly recove-
red from urine and swab specimens (38.5% each). 
According to the type of hospital ward, the hig-
hest numbers of S. hominis, S. epidermidis and S. 
haemolyticus strains were recovered from surgery 
ward (40%, 30.8%, 29.4% respectively), whereas 
S. saprophyticus was mainly recovered from pe-
diatric and surgery wards (23.1% each) (Table 2). 
As shown in Table 3, most of S. haemolyticus and 
S. epidermidis isolates were methicillin resistance 
(94.1%, 88.5% respectively) with a statistical sig-
nificant difference in comparison to its counterpart 
Table 2. Distribution of CoNS species according to the source of specimen and hospital ward.
Type of specimen
CoNS spp
Pus Swaba Urine Blood Sputum Othersb Total 
No. % No. % No. % No. % No. % No. % No. %
S. haemolyticus 14 41.2 6 17.6 5 14.7 4 11.8 2 5.9 3 8.8 34 100
S. epidermidis 9 34.6 7 26.9 4 15.4 6 23.1 0 0 0 0 26 100
S. saprophyticus 1 7.7 5 38.5 5 38.5 2 15.4 0 0 0 0 13 100
S. hominis 2 40 0 0 1 20 0 0 1 20 1 20 5 100
S. warneri 2 100 0 0 0 0 0 0 0 0 0 0 2 100
S. auricularis 0 0 1 100 0 0 0 0 0 0 0 0 1 100
Type of specimen
Hospital ward
Surgery ICU Pediatrics Medicine Burns GYN Total 
No. % No. % No. % No. % No. % No. % No. %
S. haemolyticus 10 29.4 6 17.6 6 17.6 6 17.6 5 14.7 1 2.9 34 100
S. epidermidis 8 30.8 7 26.9 6 23.1 2 7.7 3 11.5 0 0 26 100
S. saprophyticus 3 23.1 2 15.4 3 23.1 2 15.4 7.7 2 15.4 13 100
S. hominis 2 40 1 20 0 0 1 20 1 20 0 0 5 100
S. warneri 0 0 1 50 0 0 1 50 0 0 0 0 2 100
S. auricularis 0 0 0 0 0 0 1 100 0 0 0 0 1 100
a: Swabs including surgical site infections and burn swabs. b: Others including cerebrospinal, pleural, synovial and ascetic fluids. *: Statistical 
significant difference. ICUs: Intensive Care Units. GYN: Gynecology ward.
Table 3.  Distribution of CoNS species according to 
methicillin resistance (mecA positive, ce-
foxitin & oxacillin resistance.
CoNS species
MR-CoNS MS-CoNS 
P-value
No. % No. %
S. haemolyticus 32 94.1 2 5.9 < 0.0001
S. epidermidis 23 88.5 3 11.5 < 0.0001
S. saprophyticus 0 0 13 100 N.A.
S. hominis 4 80 1 20 0.07
S. warneri 1 50 1 50 not applicable
S. auricularis 0 0 1 100 not applicable
Total 60 74.1 21 25.9 < 0.001
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Table 4. Antimicrobial resistance profile of isolated clinical CoNS strains.
Antimicrobial 
agents
S. 
epidermidis
S. 
saprophyticus
S. 
hominis
S. 
warneri
S. 
auricularis
Total 
resistance
P-value
P 100 100 100 100 100 98.8 1.00
AMP 100 100 100 100 100 98.8 1.00
SAM 84.6 23.1 80 50 0 77.8 <0.001
AMC 84.6 23.1 80 50 0 77.8 <0.001
CXM 84.6 23.1 80 50 0 77.8 <0.001
CEC 84.6 23.1 80 50 0 77.8 <0.001
CTX 84.6 23.1 80 50 0 77.8 <0.001
CRO 84.6 23.1 80 50 0 77.8 <0.001
IPM 84.6 23.1 80 50 0 77.8 <0.001
ERY 30.8 69.2 100 100 100 71.6 <0.001
AZM 30.8 69.2 100 100 100 71.6 <0.001
CLR 30.8 69.2 100 100 100 71.6 <0.001
CLI 19.2 0 0 0 0 13.6 0.51
TET 19.2 30.8 40 0 0 30.9 0.08
TGC 0 0 0 0 0 3.7 0.48
GEN 34.6 0 0 0 0 45.7 <0.001
TOB 42.3 0 0 0 0 48.1 <0.001
LVX 53.8 0 0 0 0 46.9 <0.001
MXF 7.7 0 0 0 0 8.4 0.63
SXT 23.1 23.1 60 0 0 42 <0.001
RIF 0 0 0 0 0 0 -
VAN 0 0 0 0 0 0 -
TEC 0 0 0 0 0 0 -
FOF 7.7 100 100 100 100 69.1 <0.001
FUS 50 30.8 80 0 100 35.8 <0.001
NIT 0 0 0 0 0 0 -
LZD 0 0 0 0 0 0 -
MUP 0 0 0 0 0 0 -
*: Values represent percentages P: benzylpenicillin; AMP: ampicillin; SAM: ampicillin/sulbactam; AMC: amoxicillin/clavulanic acid; CXM: 
cefuroxime sodium; CEC; cefaclor; CTX: cefotaxime; CRO: ceftriaxone; IPM: imipenem; ERY: erythromycin; AZM: azithromycin; CLR: 
clarithromycin; CLI: clindamycin; TET: tetracycline; GEN: gentamycin; TGC: tigecycline; TOB: tobramycin; LVX: levofloxacin; MXF: moxifloxacin; 
SXT: trimethoprim-sulfamethoxazole; RIF: rifampin; VAN: vancomycin; TEC: teicoplanin; FOF: fosfomycin; FUS: fusidic acid; NIT: nitrofurantoin; 
LZD: linezolid; MUP: mupirocin. 
methicillin sensitive  (P< 0.0001). Surprisingly, all S. 
saprophyticus isolates were methicillin sensitive.
Antimicrobial resistance profiles 
The antimicrobial resistance profile of CoNS isolates 
to the 28 antibiotics tested was shown in Table 4 
and Figure 1. Resistance to multiple classes of anti-
microbials was observed among CoNS isolates, in-
cluding aminoglycosides, β-lactams, carbapenems, 
cephalosporins, fluoroquinolones, fosfomycin and 
macrolides. However, no resistance was detected 
to any of the following antibiotics: rifampicin, van-
comycin, teicoplanin, nitrofurantoin, linezolid and 
mupirocin. Yet, a very low to low resistance rate was 
observed to tigecycline, moxifloxacin and clinda-
mycin (3.7%, 8.4%, 13.6% respectively). CoNS stra-
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ins exhibited nearly complete resistance to penicillin 
and ampicillin (98.8% each). Rates of resistance to 
other antibiotics were 77.8% to β-lactam inhibitors, 
carbapenems and cephalosporins, 71.6% to macro-
lides, 69.1% to fosfomycin, 48.1% to tobramycin, 
46.9% to levofloxacin, 45.7% to gentamicin, 42% 
to trimethoprim/sulfamethoxazole (SXT), 35.8% to 
fusidic acid, and 30.9% to tetracycline. S. haemo-
lyticus and S. epidermidis showed a significantly 
higher resistance rate to a quite number of tested 
antibiotics in comparison to the other species. Also 
both species showed low to moderate resistance 
to clindamycin, tigecycline, gentamycin, tobramycin, 
levofloxacin and moxifloxacin in comparison to the 
other CoNS species which were completely suscep-
tible to those aforementioned antibiotics (Table 4).
Resistance to multiple classes of antimicrobials 
was found among both MR-CoNS and MS-CoNS, 
including β-lactams, macrolides, tetracycline, SXT, 
fosfomycin and fusidic acid. Overall, MR-CoNS stra-
ins exhibited complete resistance to penicillin and 
ampicillin (100%), and nearly complete resistance 
to β-lactam inhibitor antibiotics, cephalosporins and 
imipenem (98.3%) (Figure 1). Also, high resistance 
was observed to macrolides (73.3%), fosfomycin 
(63.3%), tobramycin and levofloxacin (61.7%), 
gentamicin (60%), and moderately to fusidic acid 
(38.3%) and tetracycline (35%). MS-CoNS strains 
also exhibited nearly complete resistance to peni-
cillin and ampicillin (95.2%). Resistance rate to fos-
fomycin, macrolides, fusidic acid, β-lactam inhibitor 
antibiotics and cephalosporinswas 85.7%, 66.7%, 
28.6%, 19% and 19% respectively. However, none 
of the MS-CoNS strains were resistant to clinda-
mycin and tigecyclinealong with aforementioned six 
antibiotics. The resistance rate of MR-CoNS isolates 
to β-lactam inhibitor antibiotics, cephalosporins, 
tetracycline, gentamicin, tobramycin, levofloxacin, 
SXT, and fusidic acid were significantly higher than 
those of MS-CoNS isolates (P value < 0.05) (Figu-
re 1). MDR phenotype (defined as acquired non-
susceptibility to at least one agent in three or more 
antimicrobial categories used in this study) was de-
tected in 71 isolates (88.9%).
Figure 1:  Antimicrobial resistance patterns of isolated clinical MR-CoNS and MS-CoNS strains.
P: benzylpenicillin; AMP: ampicillin; SAM: ampicillin/sulbactam; AMC: amoxicillin/clavulanic acid; CXM: cefuroxime sodium; CEC; cefaclor; CTX: cefotaxime; CRO: 
ceftriaxone; IPM: imipenem; ERY: erythromycin; AZM: azithromycin; CLR: clarithromycin; CLI: clindamycin; TET: tetracycline; GEN: gentamycin; TGC: tigecycline; 
TOB: tobramycin; LVX: levofloxacin; MXF: moxifloxacin; SXT: trimethoprim-sulfamethoxazole; RIF: rifampin; VAN: vancomycin; TEC: teicoplanin; FOF: fosfomycin; 
FUS: fusidic acid; NIT: nitrofurantoin; LZD: linezolid; MUP: mupirocin. *Statistically significant difference in resistance pattern between MR-CoNS and MS-CoNS 
(P-value < 0.05).
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Biofilm production
Out of 26 isolates of S. epidermidis examined, a 
significant number (20, 76.9%) produced biofilms 
as verified by formation of black colonies with a 
metallic sheen after 24 h of incubation on CRA 
plates and by polystyrene microtiter plate assay 
(P < 0.0001). 82.6% of which were in MR-CoNS, 
and 33.3% in MS-CoNS. Methicillin resistance was 
found to be significantly higher in biofilm positive 
strains (19, 82.6%) than in biofilm negative strains 
(4, 17.4%) (P <0.0001) (Table 5). Also, biofilm pro-
ducer strains were significantly higher among CoNS 
isolates recovered from pus, swabs and blood speci-
mens (P = 0.0013, P = 0.01, P = 0.028 respectively).
Discussion
Data regarding CoNS and MR-CoNSin Palestine 
are insufficient, with only one report from Nablus, 
Palestine [15]. Previous reports from Gaza Strip 
and West Bank of Palestine have mostly focused 
on epidemiology of S. aureus and MRSA both in 
hospital and community settings [23-27]. Here, we 
described for the first time the resistance profiles 
and biofilm formation in CoNS isolated from clini-
cal specimens in Gaza, Palestine. S. haemolyticus 
was the most common species isolated (34, 42%), 
followed by S. epidermidis (26, 32.1%). This finding 
is comparable to the findings in a study conducted 
in China where the prevalence of S. haemolyticus 
was the highest (34.1%), followed by S. epidermidis 
(27.4%) [4]. Also in another recent study in Brazil, 
S. haemolyticus was the most prevalent species [9]. 
However, many studies worldwide showed S. epi-
dermidis is the major isolated species followed by S. 
haemolyticus or other CoNS [10, 11, 28-30]. These 
differences in CoNS species rates from the worldwi-
de literature are depending on the country, hospital 
specialty, study design and setting. In this study, 
the most common clinical source of CoNS was pus 
(34.6%), followed by swabs (23.5%), urine (18.5%) 
and blood (14.8%). Two Indian studies showed that 
pus specimens were the most common source of 
CoNS [31, 32]. Furthermore, these results are nearly 
similar to the study done in Pakistan in which per-
centage of CoNS isolates in pus was 36.7%, and in 
swab was 17.3% but their findings in regard to the 
blood (45.9%) was higher [12]. Also, other studies 
revealed higher CoNS isolates from blood cultures 
as in Pakistan (53.5%) [33], Jordan (30.9%) [11], Tu-
nisia (29%) [34], and Iran (25.4%) [35]. Yet, in a 
recent study from Jordan and in accordance with 
our findings, the ICU and surgery wards accounted 
for the majority of all CoNS isolates obtained (41%) 
[11]. A plausible explanation for the differences in 
the isolation rates of CoNS from clinical source and 
wards between different countries and even some 
time in the same country may be due in part to 
differences in sample size or frequency of sampling 
and using different conventional and/or molecular 
methods among others for diagnosis. Screening 
for MR-CoNS revealed that 74.1% were MR-CoNS 
which is nearly similar to the studies done at Pakis-
tan (70.3%) [12], China (70%) [4], USA (74%) [36], 
and India (68.4%) [37]. Likewise, prevalence of MR-
CoNS in various parts of Europe is in the range of 
60-75% [38]. On the other hand, there were signifi-
cant higher rates of MR-CoNS in studies conducted 
Table 5.  Distribution of biofilm-producing S. epider-
mid is according to methicillin resistance 
and clinical source.
 S. 
epidermidis 
Biofilm 
positive 
Biofilm 
negative
P-value
26 20 76.9  6 23.1
No. % No. % No. %
Methicillin resistance
MR-CoNS 23 88.5 19 82.6 4 17.4 < 0.0001
MS-CoNS  3 11.5 1 33.3 2 66.7 0.46
Clinical source
Pus 9 34.6 8 88.9 1 11.1 0.0013
Swabs 7 26.9 6 85.7 1 14.3 0.01
Urine 4 15.4 1 25 3 75 0.19
Blood 6 23.1 5  83.1 1 16.7 0.028
Total 26 100 20 76.9 6 23.1 0.0001
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in Saudi Arabia and Poland where the prevalence 
reached 93.6% and 98% respectively [10, 39]. Yet, 
other studies found less prevalence of MR-CoNS in 
comparison to our results as from Iran (50%) [30] 
and India (32.7%) [28]. 
In this study, the resistance profile of all CoNS 
isolates showed complete to high resistance to most 
of the antibiotics tested. This pattern of resistance 
was shown in previous studies in different countries 
around the world [4, 8, 10-13, 15]. High resistance 
to the aforementioned antibiotics could be mainly 
due to excessive use, misuse, and great prescription 
of these medication in Gaza for both hospital and 
community acquired infections and also in agricultu-
re and animal feeding. Moreover, the lack of an an-
tibiotic policy and the availability of antibiotics sold 
without a medical doctor prescription in Palestine 
worsen the case [27]. In view of the high resistance 
rates of CoNS to these aforementioned antibiotics, 
treatment of infections caused by CoNS, particularly 
S. epidermidis and S. haemolyticus at Al Shifa hos-
pital with these antibiotics may not be effective. In 
contrast, no resistance of CoNS isolate was detected 
to rifampicin, vancomycin, teicoplanin, nitrofuranto-
in, linezolid and mupirocin, and very low resistance 
was detected to tigecycline and moxifloxacin (3.7%, 
8.4% respectively). Our findings are in agreement 
with many studies that showed full activity of most 
of these aforementioned antimicrobials against cli-
nical CoNS isolates [8, 11, 13, 15].Conversely, many 
reports from around the world showed different 
percentage of resistance to vancomycin, teicoplanin 
and linezolid ranging from 0.8% to 13% [4, 12, 39]. 
We think that this zero resistance in this study to 
glycopeptides and linezolid may be due to its limited 
prescription and use in Gaza Strip hospitals. So, the 
full sensitivity to vancomycin, teicoplanin and linezo-
lid can work perfectly against clinical CoNS isolated 
in Gaza hospitals as indicated against S. aureus in 
recent reports from Gaza Strip [24, 27]. On the other 
hand, a very low resistance rate was observed to 
tigecycline and moxifloxacin (3.7% and 8.4% res-
pectively). MR-CoNS showed low to moderate resis-
tance ratios against clindamycin (18.3%), tetracycline 
(35%), fusidic acid (38.3%) and gentamycin (60%). 
This picture contradicts a study conducted in Turkey 
where significantly higher resistance to clindamycin 
(72%), tetracycline (60%) and gentamycin (90%) 
was reported. Yet, fusidic acid resistance (25%) was 
lower than in our findings [40]. The least resistance 
species found in this study was S. saprophyticus. 
Same recent report from Jordan found low resis-
tance rate of S. saprophyticus isolated from urine 
samples [11]. The resistance rate of MR-CoNS isola-
tes to β-lactam inhibitor antibiotics, cephalosporins, 
tetracycline, gentamicin, tobramycin, levofloxacin, 
SXT, and fusidic acid were significantly higher than 
those of MS-CoNS isolates (P value < 0.05) (Figure 
1). This picture is mirrored others elsewhere [4, 8, 
10-13, 40]. MDR phenotype was detected in 88.9% 
of CoNS isolates. This high level of MDR in our CoNS 
collection is similar to many studies conducted in di-
fferent countries around the world as from China [4], 
Australia [5], Nigeria [8], Saudi Arabia [10], Jordan 
[11], Pakistan [12], India [13], West Bank of Palestine 
[15] and Turkey [40].
 With regard to the biofilm production, a signifi-
cant number of S. epidermidis isolates (20, 76.9%) 
were producers with significantly higher MR-CoNS 
(19, 82.6%) than MS-CoNS strains (4, 17.4%) (P < 
0.0001) (Table 5). Koksal et al., found 71% of S. 
epidermidis strains were biofilm positive with sta-
tistically significant association (P < 0.001) between 
MR-CoNS (81%) and MS-CoNS strains (57%) [40]. 
Our study has some limitations. First, it is wor-
thwhile to mention that a number of our isolates 
could be contaminants and not real pathogens. Se-
cond, we performed this study for short time in one 
referral hospital in Gaza Strip. So, this may underes-
timate or overestimate the real prevalence of CoNS 
species and MR-CoNS. Third, molecular typing was 
not performed, such that the clonality of the CoNS 
strains cannot be assessed and also the biofilm as-
sociated genes were not investigated. 
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Conclusion
Several themes of potential concern are raised by 
our findings. Most noteworthy is the high preva-
lence of MR-CoNS and its high resistance profile 
against most agents tested in this study except for 
new or not commonly used antibiotics in Gaza Strip. 
Also, most of S. epidermidis isolates were biofilm 
producers. Furthermore, high numbers of CoNS iso-
lates were shown to be MDR. These results highlight 
the critical need for monitoring and managing the 
usage of antibiotics in our hospitals and community. 
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